Evidence map›Paper›PMID 29854289›Full record

ArticleOncotarget2018

MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia.

Miriam Frech, Sabine Teichler, Christine Feld, Caroline Bouchard, Hannah Berberich, Katharina Sorg, Marco Mernberger, Lars Bullinger, Uta-Maria Bauer, Andreas Neubauer

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Emerging role of MYB transcription factors in cancer drug resistance.Cancer drug resistance (Alhambra, Calif.) · 2024
    Review
  2. Article
  3. RNA-Binding Proteins in Acute Leukemias.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Miriam Frech *Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, Marburg 35033, Germany.
Sabine Teichler *Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, Marburg 35033, Germany.
Christine Feld *Department of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, Marburg 35033, Germany.
Caroline BouchardInstitute of Molecular Biology and Tumor Research (IMT), School of Medicine, Philipps University Marburg, Marburg 35043, Germany.
Hannah BerberichInstitute of Molecular Biology and Tumor Research (IMT), School of Medicine, Philipps University Marburg, Marburg 35043, Germany.
Katharina SorgDepartment of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, Marburg 35033, Germany.
Marco MernbergerInstitute of Molecular Oncology, Philipps University Marburg, Marburg 35043, Germany.
Lars BullingerDepartment of Internal Medicine III, University Hospital of Ulm, Ulm 89081, Germany.
Uta-Maria BauerInstitute of Molecular Biology and Tumor Research (IMT), School of Medicine, Philipps University Marburg, Marburg 35043, Germany.
Andreas NeubauerDepartment of Internal Medicine and Hematology, Oncology and Immunology, Philipps University Marburg, Marburg 35033, Germany.
Institute of Molecular Biology · DEPhilipps University of Marburg · DEUniversitätsklinikum Gießen und Marburg · DEUniversity Hospital Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute myeloid leukemia (AML) arises through clonal expansion of transformed myeloid progenitor cells. The

Indexed as

acute myeloid leukemiaMYBoncogeneSKItranscriptional regulation

Identifiers

PMID29854289
PMCPMC5976475
OpenAlexW2801117232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.